Clinical Trials Logo

Clinical Trial Summary

The goal of this clinical trial is to compare different doses of AURN001 in patients with corneal edema secondary to corneal endothelial dysfunction. The main questions the clinical trial aims to answer are whether AURN001 effective and safe. Participants will receive a single injection of AURN001. A comparison between low, medium, and high doses of AURN001 against the contribution of each element, cells alone and Y27632 alone, will be conducted to determine the effects on corneal edema.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06041256
Study type Interventional
Source Aurion Biotech
Contact Study Manager, OD
Phone 18576394161
Email clinicalaffairs@aurionbiotech.com
Status Recruiting
Phase Phase 1/Phase 2
Start date October 18, 2023
Completion date October 2025

See also
  Status Clinical Trial Phase
Active, not recruiting NCT05139771 - EndoArt® Implantation in Subjects With Chronic Corneal Edema N/A
Enrolling by invitation NCT05956535 - Air Optix® Night and Day® Aqua Therapeutic Wear
Completed NCT02332109 - ODM 5 in the Treatment of Corneal Edematous Fuchs' Endothelial Dystrophy N/A
Completed NCT04498169 - A Phase 2 Study Evaluating the Safety and Efficacy of Netarsudil Ophthalmic Solution in Patients With Corneal Edema Due to Fuchs Corneal Dystrophy Phase 2
Completed NCT04521140 - Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Corneal Transplant Surgery Phase 4
Completed NCT05136443 - Loteprednol Etabonate 0.25% for Prevention of Cornea Transplant Rejection Phase 4
Completed NCT01998568 - The Intraocular Pressure Measured by Different Tonometers in Corneal Edema N/A
Recruiting NCT04191629 - Phase 1 Study to Evaluate the Safety and Tolerability of EO1404 in the Treatment of Corneal Edema Phase 1
Not yet recruiting NCT06261346 - Plasma Rich in Growth Factors in Corneal Endothelial Transplantation N/A
Completed NCT04975971 - A Retrospective Review of DEXTENZA 0.4 mg inseRt Following Corneal Transplant or Cataract Surgery
Completed NCT05309135 - A Safety and Efficacy Study of Corneal Injection for Endothelial Dysfunction Using Human Corneal Endothelial Cell Therapy in Subjects With Corneal Edema Secondary to Endothelial Dysfunction Phase 1
Completed NCT01853696 - Comparison of Corticosteroid Dosing Regimens After Endothelial Keratoplasty Phase 4
Completed NCT01244334 - Study of Difluprednate vs. Prednisolone Acetate on Visual Acuity, and Corneal Edema Following Cataract Surgery. Phase 4
Completed NCT05891106 - AONDA Therapeutic Indication Study I
Recruiting NCT04894110 - Study of Safety and Tolerability of EO2002 in the Treatment of Corneal Edema Phase 1
Completed NCT01387620 - Comparison of DisCoVisc and Hydroxypropylmethylcellulose 2% Phase 4
Completed NCT00346138 - A Comparison Between Full Thickness and Partial Thickness Corneal Transplantation for Corneal Edema N/A
Completed NCT05271058 - Effect of Intracameral Steroids During Phacoemulsification on the Cornea Phase 3
Recruiting NCT05626478 - Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Cataract Surgery Phase 4
Completed NCT01890252 - Hyper-CLâ„¢ Lens (Hyper Osmotic Contact Lens) In Subjects Suffering From Corneal Edema N/A